Phospholipase Cβ1 (PLCB1) promotes gastric adenocarcinoma metastasis by inducing epithelial mesenchymal transition and inhibiting tumour immune infiltration and is associated with poor patient prognosis.
- Author:
Lingping YUE
1
;
Junfeng CHEN
2
;
Qianqian GAO
3
Author Information
1. Department of Pathology, Changzhou Tumor Hospital Affiliated to Soochow University, Changzhou 213000, China.
2. Department of Gastrointestinal Surgery, Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi'an 710032, China.
3. Department of Pathology, Changzhou Tumor Hospital Affiliated to Soochow University, Changzhou 213000, China. *Corresponding author, E-mail: 850983312@qq.com.
- Publication Type:Journal Article
- MeSH:
Humans;
Stomach Neoplasms/genetics*;
Epithelial-Mesenchymal Transition;
Male;
Female;
Middle Aged;
Prognosis;
Adenocarcinoma/genetics*;
Cadherins/metabolism*;
Aged;
Adult;
CD8-Positive T-Lymphocytes/immunology*;
Vimentin/metabolism*;
Lymphatic Metastasis;
Neoplasm Metastasis
- From:
Chinese Journal of Cellular and Molecular Immunology
2025;41(5):444-449
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate whether PLCB1 expression leads to gastric adenocarcinoma metastasis and poor prognosis, and to preliminarily analyze its mechanism. Methods 122 gastric adenocarcinoma patients and their adjacent non-cancerous tissues were selected, and tissue microarray technology was used to detect the expression levels of PLCB1, epithelial cadherin(E-cadherin), vimentin and CD8+ T cells by immunohistochemistry, and scored by two pathologists. According to the immunohistochemical score of PLCB1, the patients were divided into PLCB1 high expression group (IHC>90) and PLCB1 low expression group (IHC≤90). The clinical pathological characteristics, epithelial mesenchymal transition(EMT)-related proteins and CD8+ T cells expression differences between the two groups were compared. The overall survival of the patients was collected, and COX regression analysis and Kaplan-Meier curve were used to evaluate the relationship between PLCB1 expression level and prognosis. Results PLCB1 was highly expressed in 55 cases of gastric adenocarcinoma tissues, while only 12 cases in adjacent non-cancerous tissues. The tumor invasion depth, lymph node metastasis degree and TNM stage of the PLCB1 high expression group were higher than those of the PLCB1 low expression group. Chi-square test showed that PLCB1 expression level was negatively correlated with E-cadherin (r=-0.339), positively correlated with vimentin (r=0.211), and negatively correlated with CD8+ T cells (r=-0.343). Kaplan-Meier curve analysis showed that the overall survival and disease-free survival of gastric adenocarcinoma patients with high PLCB1 expression were significantly reduced. Multivariate COX regression analysis showed that except for lymph node metastasis, tumor invasion depth, TNM stage, E-cadherin and vimentin were also independent prognostic factors for gastric adenocarcinoma patients. Conclusion PLCB1 is highly expressed in gastric adenocarcinoma, and is closely related to tumor aggressiveness and prognosis. PLCB1 may induce EMT and inhibit CD8+ T cell infiltration to affect gastric adenocarcinoma metastasis and immune response.
